... forpatients withtype2 diabetes. JAMA: The Journal of the American MedicalAssociation 20 10, 304 :22 98 -22 99.6. Park Y-H, Song M, Cho B-L, Lim J-Y, Song W, Kim S-H: The effects of anintegrated ... Accepted: 2 August 20 11Published: 2 August 20 11Ng et al. Health and Quality of Life Outcomes 20 11, 9:59http://www.hqlo.com/content/9/1/59Page 4 of 5 SHOR T REPOR T Open AccessHealth status of ... of anaerobic exercise training program on quality of life in type2 diabetes. The Diabetes Educator 20 03, 29 :837-846.doi:10.1186/1477-7 525 -9-59Cite this article as: Ng et al.: Health status...
... QALY 2. 40 2. 50 2. 43 2. 54 2. 47 2. 45 2. 56ICUR (Baht/QALY) 125 ,000 119,904 123 ,457 118,110 121 ,457 122 ,150 117,096% Difference in ICUR from base case (Decision tree 1) - 4.08 1 .23 5.51 2. 83 2. 28 ... statistic -2. 16 -2. 07 -2. 68 1.04 1 .24 1 .29 Nephropathy (No) 27 8 0.77 0. 82 0.75Nephropathy (Yes) 25 0.67 0.75 0.68Difference 0.10* 0.07** 0.07**Z statistic -2. 57 -2. 70 -2. 75 0.95 1.07 1. 02 Cardiovascular ... alsocomparable to that of a previous study which showed that type 2diabetes provided the mean EQ-5D score of 0.75 [26 ]. Both UK and US scores had more agreement with each other than with the Japan scores....
... diabetes. The scope of the problem. Diabetes Care 20 05, 28 :25 43 -25 45.9. Meece J: Dispelling myths and removing barriers about insulinin type2 diabetes. Diabetes Educator 20 06, 32( 1):9S-18S.10. ... management of type 2diabetes mellitus: rationale for rational use of insulin. MayoClin Proc 20 03, 78:459-467.3. Wallace TM, Matthews DR: Poor glycaemic control in type 2 diabetes: a conspiracy of ... appraisal of insulin therapy and depressionin insulin-naïve patients withtype2 diabetes. Diabetes 20 07,A504:19 92- P.19. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence of co-morbid...
... diabetes. Qual Life Res 20 04, 13:1153-1161. 12. Coffey JT, Brandle M, Zhou H, Marriott D, Burke R: Valuing health-related quality of life in diabetes. Diabetes Care 20 02, 25 :22 38 -22 43.13. Redekop ... duration ofdiabetesof 20 .9 (SD 12. 4) years(median of 19.0 years), with a median age of diagnosis of 12. 0 years (Table 2) The majority of respondents were ata normal weight (47.9%) at diagnosis, with ... Health-related quality of life and treat-ment satisfaction in Dutch patients withtype2 diabetes. Diabetes Care 20 02, 25 :458-463.14. Koopmanschap M: Coping withtype II diabetes: the patient'sperspective....
... management of type 2diabetes mellitus: rationale for rational use of insulin. MayoClin Proc 20 03, 78:459-467.3. Wallace TM, Matthews DR: Poor glycaemic control in type 2 diabetes: a conspiracy of ... diabetes. The scope of the problem. Diabetes Care 20 05, 28 :25 43 -25 45.9. Meece J: Dispelling myths and removing barriers about insulinin type2 diabetes. Diabetes Educator 20 06, 32( 1):9S-18S.10. ... control with diet,sulphonylurea, metformin, or insulin in patients withtype 2 diabetes mellitus: progressive requirement for multipletherapies (UKPDS49). JAMA 20 12, 28 1 :20 05-1999. 2. Chan...
... withtype2 diabetes. Ninety one pointtwo percentof respondents were classified as type2 and6.4% as type 1 (2. 4% were unclassified due to missinginformation or presence of another typeof ... European-American patients withtype2 diabetes. Diabetes Care 20 00, 23 :26 7 -27 2. 29 . Romon I, Fosse S, Eschwege E, Simon D, Weill A, Varroud-Vial M,Detournay B, Fagot-Campagna A: Prevalence of macrovascularcomplications ... HealthProfile (DHP-1) for use with patients withType2diabetes mellitus:psychometric evaluation and cross-cultural comparison. Diabet Med 20 00,17:5 72- 580.18. An update on the Diabetes Health Profile...